首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Sinusoidal Obstruction Syndrome and Postoperative Complications Resulting from Preoperative Chemotherapy for Colorectal Cancer Liver Metastasis
【24h】

Sinusoidal Obstruction Syndrome and Postoperative Complications Resulting from Preoperative Chemotherapy for Colorectal Cancer Liver Metastasis

机译:术前化疗对结直肠癌肝转移产生的正弦梗阻综合征和术后并发症

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background/Aim: The aim of this study was to investigate the effects of preoperative chemotherapy on the healthy, metastasis-free part of the liver in colorectal cancer patients with liver metastasis, and the relationship between chemotherapy and postoperative complications. Patients and Methods: Our study included 90 cases of colorectal cancer liver metastasis resected after preoperative chemotherapy. The patients were divided into three groups according to the received chemotherapy regimen: 20 cases received mFOLFOX6, 54 cases a combination of mFOLFOX6 with bevacizumab, and 16 cases a combination of mFOLFOX6 and cetuximab or panitumumab. Results: The mean numbers of sinusoidal injuries for each chemotherapy type were compared. The group treated with the combination of mFOLFOX6 and bevacizumab showed a lower extent of sinusoidal injury relative to other groups; this intergroup difference became increasingly remarkable as the number of chemotherapy cycles increased. Complications of various extents were found in all three groups, but no significant differences were observed between the three groups. Conclusion: In cases where preoperative chemotherapy was extended over a long period, combined use of bevacizumab was thought to be effective because of stabilization of disturbed liver hemodynamics resulting from sinusoidal injury suppression effects, allowing effective distribution of anti-cancer agents to tumors.
机译:背景/目的:本研究的目的是探讨术前化疗对肝脏转移的结肠直肠癌患者的健康,转移部分的肝脏的影响,以及化疗与术后并发症之间的关系。患者和方法:我们的研究包括在术前化疗后90例结直肠癌肝转移。根据所接受的化疗方案将患者分为三组:20例均法MFOLFOX6,54例MFOLFOX6与贝伐单抗的组合,16例MFOLFOLO6和CETUXIMAB或PANITUMUMAB的组合。结果:比较了每种化疗型正弦损伤的平均数量。用MfolfoX6和Bevacizumab的组合治疗的组在相对于其他群体中表现出较低程度的正弦损伤;随着化疗循环的数量增加,这种杂项差异变得越来越显着。在所有三组中发现了各种范围的并发症,但三组之间没有观察到显着差异。结论:在长期延长术前化疗的情况下,由于窦骨损伤抑制作用导致的干扰肝血流动力学的稳定,贝伐单抗的结合使用被认为是有效的,允许有效分布抗癌剂对肿瘤的抗癌剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号